Angioplasty in acute myocardial infarction. Early and late results;Angioplastia en infarto agudo de miocardio. Resultado inicial y seguimiento alejado

Revista Medica de Chile

Volumn 127, Issue 5, 1999, Pages 565-575

  Ugalde P, Héctor ^a   Ramírez N, Alfredo ^a   Benavente M, David ^a   Antúnez R, Miguel ^a   García B, Sebastián ^a   Dussaillant N, Gastón ^a   Ayala R, Francisco ^a   Silva J, Ana María ^a   Farías Ch, Eric ^a   Villegas R, Rodrigo ^a  

^a HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Angiography; Angioplasty; Coronary angiography; Myocardial infarction; Percutaneous coronary; Transluminal

Indexed keywords

ADULT; AGED; ANGIOPLASTY; ARTICLE; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0033124135     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. GUPPO ITALIANO PER LO STUDIO DELLA STRETOCHINASI NELL'INFARCTO MIOCARDICO (GISSI). Effectiveness of intravenous trombolytic therapy in acute myocardial infarction. Lancet 1986; 1: 397-402.
2. LIEU TA, GORLEY J, LUNDSDTROM RJ, PARMLEY WW. Primary angioplasty and thrombolysis for acute myocardial infarction: An evidence summary. J Am Coll Cardiol 1996; 27: 737-50.
3. STONE GW, GRINES CL, BROWN KF, MARCO J, ROTHBAUM D, O'KEEFE J ET AL. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary coronary angioplasty. J Am Coll Cardiol 1995; 26: 66-72.
4. THE GUSTO INVESTIGATORS. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
5. GEBEL JM, SILA CA, SLOAN MA, GRANGER CB, MAHAFFEY KW, WEISENBERGER J ET AL. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke 1998; 29: 563-9.
6. STONE GW, GRINES CL, BROWNE KF, MARCO J, ROTHBAUM D, O'KEEFE JH ET AL. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Cathet Cardiovasc Diagn 1996; 39: 333-9.
7. O'KEEFE JH JR, BAILEY WL, RUTHERFORD BD, HARTZLER GO. Primary angioplasty for acute myocardial infarction in 1,000 consecutive patients. Results in an unselected population and high-risk subgroups. Am J Cardiol 1993; 72: 107G-115G.
8. GRINES CL, BROWN KR, MARCO J, ROTHBAUM D, STONE GW, O'KEEFE J ET AL. A comparison of primary angioplasty with thrombolitic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-9.
9. ZIJLSTRA F, DE BOER MJ, HOORNTJE JC, REIFFERS S, REIBER JH, SURYAPRANATA H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
10. EVERY NR, PARSONS LS, HLATKY M, MARTIN JS, WEAVER WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med 1996; 335: 1253-60.
11. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. The global use of strategies to open occluded coronary arteries in acute coronary syndromes (GUSTO IIb) angioplasty substudy investigators. N Engl J Med 1997; 336: 1621-8.
12. OHMAN EM, CALIFF RM, TOPOL EJ, CANDELA R, ABBOTTSMITH C, ELLIS S ET AL. Consecuences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation 1990; 82: 781-91.
13. TIMI STUDY GROUP. The thrombolysis in myocardial infarction trial. Phase I: Findings. N Engl J Med 1985; 312: 932.
14. NAKAGAWA Y, IWASAKI Y, KIMURA T, TAMURA T, YOKOI H, YOKOI H ET AL. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infaction. Am J Cardiol 1996; 78: 980-4.
15. BRODIE BR, GRINES CL, IVANHOE R, KNOPF W, TAYLOR G, O'KEEFE J ET AL. Six-months clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty Registry. Circulation 1994; 25: 156-62.
16. WEAVER WD, CERQUEIRA M, HALLSTROM AP, LITWIN PE, MARTIN JS, KUDENCHUK PJ, EISENBERG M. Pre Hospital initiated vs hospital initiated thrombolytic therapy. The myocardial infarction triage and intervention trial. JAMA 1993; 270: 1211-6.
17. GREAT GROUP. Feasibility, safety and efficacy of domiciliary thrombolysis by general practitioners: Grampion region early anistreplase trial. BMJ 1992; 305: 548-53.
18. HIMBERT D, JULIARD JM, STEG PG. Is coronary angioplasty the best treatment of acute myocardial infarction? Presse Med 1995; 24: 1831-5.
19. ECKMAN MH, WONG JB, SALEM DN, PAUKER SG. Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets. Ann Intern Med 1992; 117: 667-76.
20. ZIJLSTRA F, BEUKEMA WP, VAN'T HOF AW, LIEM A, REIFFERS S, HOORNTJE JC ET AL. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997; 29: 908-12.
21. HIMBERT D, KARRILLON GJ, HVASS U, JULIARD JM, STEG PG, AUMONT MC ET AL. Incidence and prognosis of early primary cardiogenic shock in myocardial infarction. Arch Mal Coeur Vaiss 1994; 87: 1679-84.
22. ZAHN R, VOGT A, SEIDL K, SCHUSTER S, GULKER H, HEINRICH KW ET AL. Balloon dilatation in acute myocardial infarct in routine clinical practice: results of the register of the Working Society of Leading Cardiologic Hospital Physicians in 4,625 patients. Z Kardiol 1997; 86: 712-21.
23. VAN'T HOF AW, LIEM A, SURYAPRANATA H, HOORNTJE JC, DE BOER MJ, ZIJLSTRA F. Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction. Eur Heart J 1998; 19: 118-23.
24. ITO H, OKAMURA A, IWAKURA K, MASUYAMA T, HORI M, TAKIUCHI S ET AL. Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996; 93; 1993-9.
25. CHAMORRO H, DUCCI H, MATHEI R, ALCAÍNO M, FLORENZANO F, RAMÍREZ A ET AL. Primary coronary angioplasty as a choice treatment in the firs 6 hours following acute myocardial infarction. Rev Méd Chile 1995; 123: 727-34.
26. DUSSAILLANT G, MARTÍNEZ A, MARCHANT E, FAJURI A, CASTRO P, CORBALÁN R. Primary coronary angioplasty as early reperfusion treatment of acute myocardial infarction. Rev Méd Chile 1994; 122: 401-7.
27. CARIOU A, HIMBERT D, GOLMARD JL, JULIARD JM, BENAMER H, BOCCARA A ET AL. Sex-related differences in eligibility for reperfusion therapy and in-hospital outcome after acute myocardial infarction. Eur Heart J 1997; 18: 1583-9.
28. CHRISTIAN TF, BERGER PB, GIBBONS RJ, O'KEEFE JH, GRINES CL, DE WOOD MA ET AL. Intercenter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction. Am Heart J 1998; 135: 714-8.
29. VOGT A, NIEDERER W, PFAFFEROTT C, ENGEL HJ, HEINRICH W, MERX W ET AL. Direct percutaneous transluminal coronary angioplasty in acute myocardial infarction. Predictors of short-term outcome and the impact of coronary stenting. Study Group of The Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (ALKK). Eur Heart J 1998; 19: 917-21.
30. MOULICHON ME, MOSSARD JM, ARBOGAST R, SACREZ J, KOEGLER A, ROUL G ET AL. Acute myocardial infarction in patients over 70 years of age treated by immediate primary angioplasty. Ann Cardiol Angiol 1993; 42: 73-8.
31. STONE GW, GRINES CL, BROWNE KF, MARCO J, ROTHBAUM D, O'KEEFE J ET AL. Predictors of in-hospital and 6-months outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail. J Am Coll Cardiol 1995; 25: 370-7.
32. SAITO S, HOSOKAWA, KAMAKINA S. Primary Palmaz, Schatz stent implantation for acute myocardial infarction: The final result of Japanese PASTA trial (Abstract). Circulation 1997; 96: 595.
33. STONE GW, BRODIE BR, GRIFFIN JJ, MORICE MC, COSTANTINI C, ST GOAR FG ET AL. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI stent pilot trial. Primary Angioplasty in Myocardial Infarction Stent Pilot Trial Investigators. J Am Coll Cardiol 1998; 31: 23-30.
34. KEREIAKES DJ. Preferential benefit of platelet glycoprotein IIb/IIIa receptor blockade specific consideration by device and disease state. Am J Cardiol 1998; 81: 49E-54E.
35. SHULTZ RD, HEUSER RR, HATLER C, FREY D. Use of c7E3Fab in conjuntion with primary coronary stenting for acute myocardial infarction complicated by cardiogenic shock. Cathet Cardiovasc Diagn 1996; 39: 143-8.
36. ZAHN R, KOCH A, RUSTIGE J, SCHIELE R, WIRTZFELD A, NEUHAUS KL ET AL. J. Primary angioplasty versus thrombolysis in the treatment of acute myocardial infarction. ALKK Study Group. Am J Cardiol 1997; 79: 264-9.